Virtual Disaster Medicine

Training Center (VDMTC)

Module 3

Complications of Managing the Airway

Responses to Intubation

 

 

The larynx has the greatest afferent nerve supply of the airway. Airway reflexes require suppression for stress-free airway management, especially for endotracheal intubation.  Intensive autonomic responses may occur during placement, maintenance and removal of all airway devices.

 

 

HEMODYNAMIC CHANGES

 

Direct laryngoscopy and endotracheal intubation are both stimulating procedures that may cause intense autonomic responses.33  Tachycardia, hypertension, dysrhythmias, bronchospasm, and bronchorrhea are common; hypotension and bradycardia occur less often.  Patients with pre-existing hypertension are at higher risk.

 

The sympathetically mediated responses to mechanical stimulation of larynx, trachea-carina and bronchi may be blocked by topical or intravenous lidocaine, by giving opioids or short-acting selective α1-blockers before laryngoscopy and intubation.  Large hemodynamic responses have to be prevented in patients with coexisting cardiovascular disease. More than 11% of patients with myocardial disease develop some degree of myocardial ischemia during intubation.34  The key element is to provide an adequate depth of anesthesia with either intravenous or inhalation agents before instrumentation of the airway.

 

Fiberoptic intubation performed under adequate local anesthesia and conscious sedation is an appropriate technique to prevent major hemodynamic changes during intubation. The lowest cardiovascular responses were registered in patients after insertion of a LMA.

 

 

LARYNGOSPASM AND BRONCHOSPASM

 

Due to reflex responses to stage II of anesthesia, laryngospasm can occur during intubation.  Laryngospasm involves more than spastic closure of the vocal cords.  An infolding of the arytenoids and the aryepiglottic folds occurs; these structures are subsequently covered by the epiglottis.  This explains why a firm jaw thrust can sometimes break the spasm: the hyoid is elevated, thereby stretching the epiglottis and aryepiglottic folds to open the forced closure.  Malpositioning due to incorrect insertion techniques, as well as inadequate depth of anesthesia during LMA insertion, may induce laryngospasm.  It may also occur during fiberoptic intubation performed in non- or subanesthetized laryngeal structures.  Positive mask pressure may help; treatment with a short-acting muscle relaxant may be necessary to break the spasm.

 

Tracheal irritation from the endotracheal tube can cause bronchospasm that is sufficiently severe to prevent air movement throughout the lungs.  The incidence of intraoperative bronchospasm is almost 9% with endotracheal intubation, 0.13% with an LMA, but close to 0% with mask ventilation.35  Poor correlation is seen with age, sex, duration or severity of reactive airway disease, or duration of anesthesia.  Factors that may contribute to bronchospasm include inhaled stimulants, release of allergic mediators, viral infections, exercise, or pharmacologic factors (including α-blockers, prostaglandin inhibitors, and anticholinesterases).  Bronchospasm may also occur during fiberoptic intubation.

 

The spasm can be treated with inhalation of epinephrine or isoproterenol or an α2-agonist (such as albuterol, metaproterenol, or terbutaline) or by deepening the level of a volatile anesthetic.

 

 

COUGHING AND BUCKING

 

Two additional adverse responses to intubation are coughing and bucking.  Such responses are potentially hazardous in cases of increased intracranial pressure, intracranial vascular anomalies, open-globe injuries, ophthalmologic surgery, or in cases in which increased intra-abdominal pressure could rupture an abdominal incision.  Coughing and bucking occur less frequently with the LMA; however, in the presence of lubricant globules on the anterior surface of the cuff, light anesthesia or malpositioning, these adverse reactions may be observed.  The incidence of coughing, gagging and retching has been reported as 0.8% using an LMA with a fentanyl-propfol-O2-N2O-isoflurane technique.35

 

 

VOMITING, REGURGITATION AND ASPIRATION

 

The overall incidence of aspiration during general anesthesia varies and has been reported as 1/2131 (in Sweden) to 1/14150 (in France), and 1/3216 in the USA, with an associated mortality of 1/71829 in the USA.36  A meta-analysis of publications concerning the LMA (547 publications) suggested that the overall incidence of pulmonary aspiration was approximately 2/10000.37  An endotracheal tube and a Combitube are most effective in preventing pulmonary aspiration. To reduce the risk of pulmonary aspiration, some new designs of airway management devices were developed: the ProSeal-LMA and the Laryngeal Tube Suction™.

 

In any patient considered to have a full stomach, the likelihood of vomiting in response to irritation of the airway is increased, and aspiration of stomach contents is a constant concern. Aspiration leads to coughing, laryngospasm and bronchospasm, assuming that protective reflexes are intact.  In consequence of these reactions, hypertonia, bradycardia, asystole and hypoxia may occur.  The magnitude of the pulmonary reactions depends on the type and quantity of the aspirated material.38

 

The Sellick maneuver, or cricoid pressure, has removed much of the fear of emergency intubation.  Cricoid pressure is effective in raising the pressure in the upper esophageal sphincter, thus preventing aspiration.

 

 

INTRAOCULAR AND INTRACRANIAL PRESSURE

 

With thiopental, etomidate and halothane anesthesia, an increase in intraocular pressure was observed during laryngoscopy as well as LMA insertion, but not with TIVA or remifentanil and sevoflurane.  Decreases in intraocular pressures were observed under endotracheal intubation during general anesthesia with propofol and sevoflurane, both combined with remifentanil.  Intraocular pressure may also increase during extubation.

 

Insertion of an LMA does not increase intraocular pressure in children after sevoflurane induction.51  Sufentanil is also effective in preventing an intraocular pressure increase caused by rapid-sequence induction with succinylcholine.52  It is extremely important that an increase in intraocluar pressure should be avoided in patients with penetrating eye injury.

 

Intracranial pressure markedly and transiently rises during laryngoscopy and endotracheal intubation.  Patients with head injury are at higher risk from this increase as it reduces cerebral perfusion and thus may increase secondary brain damage.  Deep anesthesia during induction can prevent these adverse effects.

 

 

LATEX ALLERGY

 

Almost 17% of overall anaphylaxis in surgical procedures are related to latex anaphylaxis.39  To prevent anaphylaxis in patients during anesthesia and surgery, the patient’s history has to be carefully evaluated preoperatively. There is currently no therapy for latex allergy, and avoidance of latex-containing products is mandatory for predisposed individuals.40  Latex allergy is present in 8% of the general population in the USA, with a prevalence of 30% in health-care workers.41  There is an increased incidence of type I and type IV latex sensitivity in the general population.  The prevalence of latex sensitivity among anesthesiologists is approximately 12.5% and of allergy 2.4%.42

 

Patients with spina bifida, rubber industry workers, atopic patients, patients with a multiple surgery history and with certain exotic food allergies are most at risk.  Contamination with latex in anesthesia is possible through direct contact by face mask, endotracheal and gastric tubes, gloves, syringes, electrodes; through inhalation from contaminated circuits and room air; and through the parenteral path with latex-containing intravenous administration sets.

 

Considerations for anesthesiologists handling patients with latex allergy are available at the ASA’s website [http://www.asahq.org/publicationsAndServices/latexallergy.pdf].  In a pediatric study, Nakamura et al found that a high percentage of children with home mechanical ventilation have undiagnosed latex allergy.43